$CDLX
Cardlytics, Inc.
CIK:0001666071|SEC Filings
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||||
|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|||
| Income Statement [Abstract] | ||||||
| Revenues | $ 36,882 | $ 58,041 | $ 71,201 | $ 114,476 | ||
| Costs and Expenses [Abstract] | ||||||
| Partner Share and other third-party costs | 15,614 | 26,721 | 30,211 | 55,825 | ||
| Delivery costs | 2,648 | 5,356 | 5,229 | 11,142 | ||
| Sales and marketing expense | 6,605 | 8,943 | 13,366 | 19,324 | ||
| Research and development expense | 5,540 | 9,867 | 11,970 | 20,145 | ||
| General and administrative expense | 7,855 | 12,238 | 16,136 | 25,181 | ||
| Change in contingent consideration | 0 | 42 | 0 | 102 | ||
| Loss (gain) on divestiture | 0 | 200 | 0 | (5,150) | ||
| Depreciation and amortization expense | 4,061 | 4,243 | 8,004 | 8,591 | ||
| Total costs and expenses | 42,323 | 67,610 | 84,916 | 135,160 | ||
| Operating loss | (5,441) | (9,569) | (13,715) | (20,684) | ||
| Other (expense) income: | ||||||
| Interest expense, net | (2,281) | (1,943) | (4,814) | (3,773) | ||
| Loss on investments | (1,102) | 0 | (2,387) | 0 | ||
| Foreign currency gain (loss) | 165 | 5,449 | (1,541) | 8,076 | ||
| Total other (expense) income | (3,218) | 3,506 | (8,742) | 4,303 | ||
| Loss before income taxes from continuing operations | (8,659) | (6,063) | (22,457) | (16,381) | ||
| Income tax benefit | 0 | 0 | 0 | 0 | ||
| Loss from continuing operations | (8,659) | (6,063) | (22,457) | (16,381) | ||
| (Loss) income from discontinued operations | (6,217) | (3,220) | 3,101 | (6,184) | ||
| Net loss | $ (14,876) | $ (9,283) | $ (19,356) | $ (22,565) | ||
| Net (loss) income per share, basic and diluted(1): | ||||||
| Continuing operations, basic (in dollars per share) | [1] | $ (1.50) | $ (1.15) | $ (3.99) | $ (3.13) | |
| Continuing operations, diluted (in dollars per share) | [1] | (1.50) | (1.15) | (3.99) | (3.13) | |
| Discontinued operations, basic (in dollars per share) | [1] | (1.08) | (0.61) | 0.55 | (1.18) | |
| Discontinued operations, diluted (in dollars per share) | [1] | $ (1.08) | $ (0.61) | $ 0.55 | $ (1.18) | |
| Weighted-average common shares outstanding, basic (in shares) | 5,759,000 | 5,275,000 | 5,625,000 | 5,230,000 | ||
| Weighted-average common shares outstanding, diluted (in shares) | 5,759,000 | 5,275,000 | 5,625,000 | 5,230,000 | ||
| ||||||